Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Top Cited Papers
Open Access
- 28 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Infectious Diseases of Poverty
- Vol. 9 (1), 1-7
- https://doi.org/10.1186/s40249-020-00662-x
Abstract
Since its discovery in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 2 180 000 people worldwide and has caused more than 150 000 deaths as of April 16, 2020. SARS-CoV-2, which is the virus causing coronavirus disease 2019 (COVID-19), uses the angiotensin-converting enzyme 2 (ACE2) as a cell receptor to invade human cells. Thus, ACE2 is the key to understanding the mechanism of SARS-CoV-2 infection. This study is to investigate the ACE2 expression in various human tissues in order to provide insights into the mechanism of SARS-CoV-2 infection. We compared ACE2 expression levels across 31 normal human tissues between males and females and between younger (ages ≤ 49 years) and older (ages > 49 years) persons using two-sided Student’s t test. We also investigated the correlations between ACE2 expression and immune signatures in various tissues using Pearson’s correlation test. ACE2 expression levels were the highest in the small intestine, testis, kidneys, heart, thyroid, and adipose tissue, and were the lowest in the blood, spleen, bone marrow, brain, blood vessels, and muscle. ACE2 showed medium expression levels in the lungs, colon, liver, bladder, and adrenal gland. ACE2 was not differentially expressed between males and females or between younger and older persons in any tissue. In the skin, digestive system, brain, and blood vessels, ACE2 expression levels were positively associated with immune signatures in both males and females. In the thyroid and lungs, ACE2 expression levels were positively and negatively associated with immune signatures in males and females, respectively, and in the lungs they had a positive and a negative correlation in the older and younger groups, respectively. Our data indicate that SARS-CoV-2 may infect other tissues aside from the lungs and infect persons with different sexes, ages, and races equally. The different host immune responses to SARS-CoV-2 infection may partially explain why males and females, young and old persons infected with this virus have markedly distinct disease severity. This study provides new insights into the role of ACE2 in the SARS-CoV-2 pandemic.Keywords
Funding Information
- China Pharmaceutical University (3150120001)
This publication has 21 references indexed in Scilit:
- Coronavirus infections and immune responsesJournal of Medical Virology, 2020
- A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV InfectionThe Journal of Immunology, 2015
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic ActivityCell, 2015
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Case fatality of SARS in mainland China and associated risk factorsTropical Medicine & International Health, 2009
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005
- Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome than Women Do?American Journal of Epidemiology, 2004
- Evaluation of Control Measures Implemented in the Severe Acute Respiratory Syndrome Outbreak in Beijing, 2003JAMA, 2003
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society: Series B (Methodological), 1995